Variables | Years after patent expiration | ||||
---|---|---|---|---|---|
1st year | 2nd year | 3rd year | 4th year | 5th year | |
Market share of generics/biosimilar | |||||
Chemical generics | 5.0% | 7.1% | 9.2% | 11.3% | 13.4% |
Biosimilars | 3.1% | 12.5% | 12.5% | 12.5% | 12.5% |
Market growth | |||||
Chemical drugs | 1.3% | 1.4% | 1.4% | 1.4% | 1.4% |
Biologics | 4.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Price level of originatorsa | |||||
Chemical drugs | 75% | 60% | 60% | 53% | 53% |
Biologics | 80% | 80% | 80% | 80% | 80% |
Price level of generics/biosimilarsa | |||||
Chemical generics | 58% | 57% | 55% | 51% | 51% |
Biosimilars | 72% | 57% | 57% | 57% | 57% |